HOME › DRUGS › PEMIGATINIB
ACTIVE SUBSTANCE / INN

PEMIGATINIB

Brand name(s): PEMAZYRE, Pemazyre
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Cholangiocarcinoma
NDA213736
ACTIVE SUBSTANCE
Pemigatinib
REGULATORS
FDA · EMA
SPONSORS / MAH
Incyte Biosciences Distribution B.V., INCYTE CORP
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PEMAZYRENDA213736INCYTE CORPPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PemazyreIncyte Biosciences Distribution B.V.Authorised26/03/2021Cholangiocarcinoma

FULL INTELLIGENCE ON PEMIGATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →